Hyperbaric Oxygen: Applications in Infectious Disease

Emergency Medicine Clinics of North America

Volumn 26, Issue 2, 2008, Pages 571-595

  Kaide, Colin G ^a   Khandelwal, Sorabh ^a  

^a THE OHIO STATE UNIVERSITY WEXNER MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMPHOTERICIN B; ANTIINFECTIVE AGENT;

BRAIN ABSCESS; CLINICAL PROTOCOL; CLOSTRIDIUM BIFERMENTANS; CLOSTRIDIUM HISTOLYTICUM; CLOSTRIDIUM PERFRINGENS; COMORBIDITY; DEBRIDEMENT; DIABETIC FOOT; EXTERNAL OTITIS; FOOT ULCER; GAS GANGRENE; HYPERBARIC OXYGEN; INFECTION; MUCORMYCOSIS; NECROTIZING FASCIITIS; OSTEOMYELITIS; OXYGEN THERAPY; PRIORITY JOURNAL; REVIEW; TREATMENT INDICATION;

EID: 41749108659     PISSN: 07338627     EISSN: 07338627     Source Type: Journal    
DOI: 10.1016/j.emc.2008.01.005     Document Type: Review

References (102)

1. In: Feldmeier J.J. (Ed). Hyperbaric oxygen 2003: indications and results: the Hyperbaric Oxygen Therapy Committee Report (2003), Undersea and Hyperbaric Medical Society, Kensington (MD) 2
2. VanUnnik A. Inhibition of toxin production in Clostridium perfringens in vitro by hyperbaric oxygen. Antonie Leeuwenhoek Microbiology 31 (1965) 181-186
3. Hohn D., et al. Effect of oxygen tension on microbicidal function of leukocytes in wounds and in vitro. Surg Forum 27 (1976) 18-20
4. Hunt T., et al. The effect of differing ambient oxygen tensions on wound infection. Ann Surg 181 (1975) 35-39
5. Babior B. Oxygen-dependent microbial killing by phagocytes. N Engl J Med 298 (1978) 659-668
6. Jonsson K., and Hunt T.K. Oxygen as an isolated variable influences resistance to infection. Ann Surg 208 6 (1988) 783-787
7. Knighton D., Halliday B., and Hunt T.H. Oxygen as an antibiotic: a comparison of inspired oxygen concentration and antibiotic administration on in vivo bacterial clearance. Arch Surg 121 (1986) 191-195
8. Park M., et al. Hyperoxia prolongs the aminoglycoside-induced post antibiotic effect in Pseudomonas aeruginosa. Antimicrob Agents Chemother 35 (1991) 691-695
9. Gottlieb S.F., et al. Synergistic action of increased oxygen tensions and PABA-folic acid antagonists on bacterial growth. Aerosp Med 45 8 (1974) 829-833
10. Norden C.W., and Shaffer M. Treatment of experimental chronic osteomyelitis due to staphylococcus aureus with vancomycin and rifampin. J Infect Dis 147 2 (1983) 352-357
11. Smith J., and Lewin C. Chemistry and mechanisms of action of the quinolone antibacterials. In: Andriole V. (Ed). The quinolones (1988), Acad Press, New York 23-82
12. Kivisaari J., and Niinikoski J. Effects of hyperbaric oxygenation and prolonged hypoxia on the healing of open wounds. Acta Chir Scand 141 (1975) 14-19
13. Mandell G.L., et al. Mandell, Douglas, and Bennett's principles and practice of infectious diseases (2005), Churchill-Livingston, NewYork
14. Jallali W.S., and Butler P.E. Hyperbaric oxygen as adjuvant therapy in the management of necrotizing fasciitis. Am J Surg 189 4 (2005) 462-466
15. Levine E.G., and Manders S.M. Life-threatening necrotizing fasciitis. Clin Dermatol 23 2 (2005) 144-147
16. Brook I., and Frazier E. Clinical and microbiological features of necrotizing fasciitis. J Clin Microbiol 33 9 (1995) 2382-2387
17. Hasham S., et al. Necrotising fasciitis. BMJ 330 7495 (2005) 830-833
18. Miller L.G., et al. Necrotizing fasciitis caused by community-associated methicillin-resistant Staphylococcus aureus in Los Angeles. N Engl J Med 352 14 (2005) 1445-1453
19. Childers B.J., et al. Necrotizing fasciitis: a fourteen-year retrospective study of 163 consecutive patients. Am Surg 68 2 (2002) 109-116
20. McHenry C.R., et al. Idiopathic necrotizing fasciitis: recognition, incidence, and outcome of therapy. Am Surg 60 7 (1994) 490-494
21. Bakker D. Selected aerobic and anaerobic soft tissue infections. In: Kindwall E., and Whelan H. (Eds). Hyperbaric medicine practice (2004), Best Pub. Co., Flagstaff (AZ) 575-601
22. Jallali N. Necrotising fasciitis: its aetiology, diagnosis and management. J Wound Care 12 (2003) 297-300
23. Escobar S.J., et al. Adjuvant hyperbaric oxygen therapy (HBO2) for treatment of necrotizing fasciitis reduces mortality and amputation rate. Undersea Hyperb Med 32 6 (2005) 437-443
24. Mader J. Mixed anaerobic and aerobic soft tissue infections. In: Davis J., and Hunt T. (Eds). Problem wounds: the role of oxygen (1988), Elsevier, New York 153-172
25. Riseman J.A., et al. Hyperbaric oxygen therapy for necrotizing fasciitis reduces mortality and the need for débridements. Surgery 108 5 (1990) 847-850
26. Tehrani M., and Ledingham M. Necrotising fasciitis. Postgrad Med J 53 (1977) 237-242
27. Hart G., Lamb R., and Strauss M. Gas gangrene. J Trauma 23 11 (1983) 991-1000
28. Heimbach R. Gas gangrene. In: Kindwall E., and Whelan H. (Eds). Hyperbaric medicine practice (2004), Best Pub. Co., Flagstaff (AZ) 549-565
29. Bakker D. Clostridial myonecrosis (gas gangrene). In: Feldmeier J. (Ed). Hyperbaric Oxygen Therapy Committee Report 2003 (2003), Undersea and Hyperbaric Medical Society, Dunkirk (France) 19-25
30. Titball R.W. Gas gangrene: an open and closed case. Microbiology 151 Pt 9 (2005) 2821-2828
31. Awad M.M., et al. Virulence studies on chromosomal alpha-toxin and theta-toxin mutants constructed by allelic exchange provide genetic evidence for the essential role of alpha-toxin in Clostridium perfringens-mediated gas gangrene. Mol Microbiol 15 2 (1995) 191-202
32. Demello F, et al. The effects of hyperbaric oxygen on the germination and toxin production of Clostridium perfringens spores. In: Proceedings of the fourth international congress on hyperbaric medicine. Baltimore (MD): Williams & Wilkins.
33. Demello F.J., Haglin J.J., and Hitchcock C.R. Comparative study of experimental Clostridium perfringens infection in dogs treated with antibiotics, surgery, and hyperbaric oxygen. Surgery 73 6 (1973) 936-941
34. Peirce E.I. Gas gangrene: a critique of therapy. Surg Rounds 7 (1984) 17-25
35. Heimbach R., et al. Current therapy of gas gangrene. In: Davis J., and Hunt T. (Eds). Hyperbaric oxygen therapy (1977), Undersea Medical Society, Inc, Bethesda (MD) 153
36. Bakker D. Clostridial myonecrosis. In: Bakker D., and Cramer F. (Eds). Hyperbaric surgery (2002), Best Publ., Flagstaff (AZ) 283-316
37. Tibbles P.M., and Edelsberg J.S. Hyperbaric-oxygen therapy. N Engl J Med 334 25 (1996) 1642-1648
38. Lew D.P., and Waldvogel F.A. Osteomyelitis. Lancet 364 9431 (2004) 369-379
39. Strauss M. Chronic refractory osteomyelitis: review and role of hyperbaric oxygen. Hyperbaric Oxygen Review 1 (1980) 231-256
40. Mader J.T., et al. Antimicrobial treatment of chronic osteomyelitis. Clin Orthop Relat Res 360 (1999) 47-65
41. Mader J.T., et al. A mechanism for the amelioration by hyperbaric oxygen of experimental staphylococcal osteomyelitis in rabbits. J Infect Dis 142 6 (1980) 915-922
42. Niinikoski J., and Hunt T.K. Oxygen tensions in healing bone. Surg Gynecol Obstet 134 5 (1972) 746-750
43. Hohn D. Oxygen and leukocyte microbial killing. In: Davis J., and Hunt T. (Eds). Hyperbaric oxygen therapy (1977), Undersea and Hyperbaric Medical Society, Bethesda (MD) 101-110
44. Hart B.B. Refractory osteomyelitis. In: Feldmeier J.J. (Ed). Hyperbaric oxygen 2003: indications and results: the Hyperbaric Oxygen Therapy Committee Report (2003), Undersea and Hyperbaric Medical Society, Kensington (MD) 79-85
45. Slack W.K. Hyperbaric oxygen therapy in anaerobic infections. Med Times 106 10 (1978) 15d82-16d82 21d(82)
46. Park M.K., Myers R.A., and Marzella L. Oxygen tensions and infections: modulation of microbial growth, activity of antimicrobial agents, and immunologic responses. Clin Infect Dis 14 3 (1992) 720-740
47. Verklin Jr. R.M., and Mandell G.L. Alteration of effectiveness of antibiotics by anaerobiosis. J Lab Clin Med 89 1 (1977) 65-71
48. Slack W.K., Thomas D.A., and Perrins D. Hyperbaric oxygenation chronic osteomyelitis. Lancet 1 (1965) 1093-1094
49. Morrey B.F., et al. Hyperbaric oxygen and chronic osteomyelitis. Clin Orthop Relat Res 144 (1979) 121-127
50. Davis J.C., et al. Chronic non-hematogenous osteomyelitis treated with adjuvant hyperbaric oxygen. J Bone Joint Surg Am 68 8 (1986) 1210-1217
51. Bingham E.L., and Hart G.B. Hyperbaric oxygen treatment of refractory osteomyelitis. Postgrad Med 61 6 (1977) 70-76
52. Depenbusch F.L., Thompson R.E., and Hart G.B. Use of hyperbaric oxygen in the treatment of refractory osteomyelitis: a preliminary report. J Trauma 12 9 (1972) 807-812
53. Chen C.Y., et al. Chronic refractory tibia osteomyelitis treated with adjuvant hyperbaric oxygen: a preliminary report. Changgeng Yi Xue Za Zhi 21 2 (1998) 165-171
54. Aitasalo K., et al. A modified protocol to treat early osteoradionecrosis of the mandible. Undersea Hyperb Med 22 2 (1995) 161-170
55. Maynor M.L., et al. Chronic osteomyelitis of the tibia: treatment with hyperbaric oxygen and autogenous microsurgical muscle transplantation. J South Orthop Assoc 7 1 (1998) 43-57
56. Esterhai Jr. J.L., et al. Adjunctive hyperbaric oxygen therapy in the treatment of chronic refractory osteomyelitis. J Trauma 27 7 (1987) 763-768
57. Cierny G., Mader J., and Pennick J. A clinical staging system for adult osteomyelitis. Contemp Orthop 10 (1985) 17-37
58. Mader J., and Davis J. General concept of osteomyelitis. In: Mandell G., Bennet J., and Dolin R. (Eds). Principles and practice of infectious disease (1995), Churchill Livingston, New York
59. Strauss M.B., and Bryant B. Hyperbaric oxygen. Orthopedics 25 3 (2002) 303-310
60. Strauss M. The role of hyperbaric oxygen in the surgical management of chronic refractory osteomyelitis. In: Bakker D.J., and Cramer F.S. (Eds). Hyperbaric surgery (2002), Best Publishing, Flagstaff (AZ) 59
61. Kontoyiannis D.P., and Lewis R.E. Invasive zygomycosis: update on pathogenesis, clinical manifestations, and management. Infect Dis Clin North Am 20 3 (2006) 581-607 vi
62. John B.V., Chamilos G., and Kontoyiannis D.P. Hyperbaric oxygen as an adjunctive treatment for zygomycosis. Clin Microbiol Infect 11 7 (2005) 515-517
63. Mandell G.L. Bactericidal activity of aerobic and anaerobic polymorphonuclear neutrophils. Infect Immun 9 2 (1974) 337-341
64. Gupta S., et al. Infections in diabetes mellitus and hyperglycemia. Infect Dis Clin North Am 21 3 (2007) 617-638 vii
65. Farmer J., and Kindwall E. Use of adjunctive hyperbaric oxygen in the management of fungal disease. In: Feldmeier J. (Ed). Hyperbaric oxygen 2003: indications and results: the Hyperbaric Oxygen Therapy Committee Report (2004), Undersea and Hyperbaric Medical Society, Dunkirk (France) 656-661
66. Price J.C., and Stevens D.L. Hyperbaric oxygen in the treatment of rhinocerebral mucormycosis. Laryngoscope 90 5 Pt 1 (1980) 737-747
67. Ferguson B.J., et al. Adjunctive hyperbaric oxygen for treatment of rhinocerebral mucormycosis. Rev Infect Dis 10 3 (1988) 551-559
68. Couch L., Theilen F., and Mader J.T. Rhinocerebral mucormycosis with cerebral extension successfully treated with adjunctive hyperbaric oxygen therapy. Arch Otolaryngol Head Neck Surg 114 7 (1988) 791-794
69. De La Paz M.A., et al. Adjunctive hyperbaric oxygen in the treatment of bilateral cerebro-rhino-orbital mucormycosis. Am J Ophthalmol 114 2 (1992) 208-211
70. Yohai R.A., et al. Survival factors in rhino-orbital-cerebral mucormycosis. Surv Ophthalmol 39 1 (1994) 3-22
71. Segal E., Menhusen M.J., and Shawn S. Hyperbaric oxygen in the treatment of invasive fungal infections: a single-center experience. Isr Med Assoc J 9 5 (2007) 355-357
72. Simmons J.H., et al. Rhinocerebral mucormycosis complicated by internal carotid artery thrombosis in a pediatric patient with type 1 diabetes mellitus: a case report and review of the literature. Pediatr Diabetes 6 4 (2005) 234-238
73. Reiber G.E., and Smith D.G. Lower extremity foot ulcers and amputations in diabetes. In: National Diabetes Data Group, National Institutes of Health, and National Institute of Diabetes and Digestive and Kidney Diseases (Eds). Diabetes in America (1995) 409-428
74. Ramsey S.D., et al. Incidence, outcomes, and cost of foot ulcers in patients with diabetes. Diabetes Care 22 3 (1999) 382-387
75. Moulik P.K., Mtonga R., and Gill G.V. Amputation and mortality in new-onset diabetic foot ulcers stratified by etiology. Diabetes Care 26 2 (2003) 491-494
76. Falanga V. Wound healing and its impairment in the diabetic foot. Lancet 366 9498 (2005) 1736-1743
77. Consensus Development Conference on Diabetic Foot Wound Care: 7-8 April 1999, Boston, Massachusetts. American Diabetes Association. Diabetes Care 22 8 (1999) 1354-1360
78. O'Meara S., et al. Systematic reviews of wound care management: (3) antimicrobial agents for chronic wounds; (4) diabetic foot ulceration. Health Technol Assess 4 21 (2000) 1-237
79. Lipsky B.A., et al. Diagnosis and treatment of diabetic foot infections. Clin Infect Dis 39 7 (2004) 885-910
80. Hunt T.K., and Pai M.P. The effect of varying ambient oxygen tensions on wound metabolism and collagen synthesis. Surg Gynecol Obstet 135 4 (1972) 561-567
81. Knighton D.R., Silver I.A., and Hunt T.K. Regulation of wound-healing angiogenesis-effect of oxygen gradients and inspired oxygen concentration. Surgery 90 2 (1981) 262-270
82. Zhao L.L., et al. Effect of hyperbaric oxygen and growth factors on rabbit ear ischemic ulcers. Arch Surg 129 10 (1994) 1043-1049
83. Berendt A.R. Counterpoint: hyperbaric oxygen for diabetic foot wounds is not effective. Clin Infect Dis 43 2 (2006) 193-198
84. Barnes R.C. Point: hyperbaric oxygen is beneficial for diabetic foot wounds. Clin Infect Dis 43 2 (2006) 188-192
85. Roeckl-Wiedmann I., Bennett M., and Kranke P. Systematic review of hyperbaric oxygen in the management of chronic wounds. Br J Surg 92 1 (2005) 24-32
86. Shuren J, et al. Coverage decision memorandum for hyperbaric oxygen therapy in the treatment of hypoxic wounds and diabetic wounds of the lower extremities. 2002.
87. Wagner Jr. F.W. The dysvascular foot: a system for diagnosis and treatment. Foot Ankle 2 2 (1981) 64-122
88. Smith R.G. Validation of Wagner's classification: a literature review. Ostomy Wound Manage 49 1 (2003) 54-62
89. Feldmeier JJ. chairman and editor. Chapter reviewed by Irving Jacoby. Intracranial abscess. In: Feldmeier J.J. (Ed). Hyperbaric oxygen 2003: indications and results: the Hyperbaric Oxygen Therapy Committee Report (2003), Undersea and Hyperbaric Medical Society, Kensington (MD) 63-65 63-7
90. Mogami H., et al. Clinical application of hyperbaric oxygenation in the treatment of acute cerebral damage. J Neurosurg 31 6 (1969) 636-643
91. Moody R.A., et al. Therapeutic value of oxygen at normal and hyperbaric pressure in experimental head injury. J Neurosurg 32 1 (1970) 51-54
92. Pierce E.C.I., and Jacobson II J.H. Cerebral edema. In: Davis J.C., and Hunt T.K. (Eds). Hyperbaric oxygen therapy (1977), Undersea Medical Society, Bethesda (MD) 287-301
93. Lampl L., and Frey G. Hyperbaric oxygen in intracranial abscess. In: Kindwall E., and Whelan H. (Eds). Hyperbaric medicine practice (2004), Best Publishing Company, Flagstaff (AZ) 645-654
94. Kutlay M., et al. Stereotactic aspiration and antibiotic treatment combined with hyperbaric oxygen therapy in the management of bacterial brain abscesses. Neurosurgery 57 6 (2005) 1140-1146 [discussion: 1140-6]
95. Kurschel S., et al. Hyperbaric oxygen therapy for the treatment of brain abscess in children. Childs Nerv Syst 22 1 (2006) 38-42
96. Davis J.C., et al. Adjuvant hyperbaric oxygen in malignant external otitis. Arch Otolaryngol Head Neck Surg 118 1 (1992) 89-93
97. Narozny W., et al. Value of hyperbaric oxygen in bacterial and fungal malignant external otitis treatment. Eur Arch Otorhinolaryngol 263 7 (2006) 680-684
98. Eltorai I.M., Hart G.B., Strauss M.B., et al. The role of hyperbaric oxygen in the management of Fournier's gangrene. Int Surg 71 (1986) 53
99. Gozal D., Ziser A., et al. Necrotizing fasciitis. Archives of Surgery 121 2 (1986) 233-235
100. Brown D.R., Davis N.L., et al. A multicenter review of the treatment of major truncal necrotizing infections with and without hyperbaric oxygen therapy. Am J Surg 167 (1994) 485-489
101. Shupak A., Shoshani O., et al. Necrotizing fasciitis: an indication for hyperbaric oxygen therapy?. Surgery 118 5 (1995) 873-878
102. Korhonen K., Hirn M., and Niinikoski J. Hyperbaric oxygen in the treatment of Fournier's gangrene. Eur J Surg 164 4 (1998) 251-255